Development and external validation of an admission-based model for 180-day mortality in diabetic acute myocardial infarction - Takeaways - MDSpire

Development and external validation of an admission-based model for 180-day mortality in diabetic acute myocardial infarction

  • By

  • Yanlong Zhao

  • Haodong Jiang

  • Yuanyuan Zhao

  • Shuai Wang

  • Qicheng Yu

  • Jing Zeng

  • Shan Xie

  • Jiatong Li

  • Zhi Liu

  • July 2, 2026

  • 0 min

Share

  • 1

    A retrospective dual-cohort study assessed admission risk heterogeneity in patients with diabetic acute myocardial infarction (DM-AMI).

  • 2

    The study developed a model for predicting 180-day mortality using eight admission variables, including age and glucose levels.

  • 3

    The model demonstrated good discrimination in the development cohort with a C-index of 0.848 and maintained performance in external validation.

  • 4

    Comparison with the GRACE score showed similar discrimination, but the combined model improved performance with a significant ΔAUC.

  • 5

    The model requires recalibration for accurate risk assessment in external settings due to observed risk overestimation in validation.

Original Source(s)

Related Content